81 related articles for article (PubMed ID: 9150386)
1. Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblasts.
Ciana P; Neri A; Cappellini C; Cavallo F; Pomati M; Chang CC; Maiolo AT; Lombardi L
Oncogene; 1997 Apr; 14(15):1805-10. PubMed ID: 9150386
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.
Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
Oncogene; 1994 Mar; 9(3):923-33. PubMed ID: 8108136
[TBL] [Abstract][Full Text] [Related]
3. Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators.
Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
Mol Cell Biol; 1995 Sep; 15(9):5180-7. PubMed ID: 7651435
[TBL] [Abstract][Full Text] [Related]
4. Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-kappaB have a malignantly transformed phenotype.
Gapuzan ME; Yufit PV; Gilmore TD
Oncogene; 2002 Apr; 21(16):2484-92. PubMed ID: 11971183
[TBL] [Abstract][Full Text] [Related]
5. Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies.
Fracchiolla NS; Lombardi L; Salina M; Migliazza A; Baldini L; Berti E; Cro L; Polli E; Maiolo AT; Neri A
Oncogene; 1993 Oct; 8(10):2839-45. PubMed ID: 8378093
[TBL] [Abstract][Full Text] [Related]
6. Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions.
Zhang J; Chang CC; Lombardi L; Dalla-Favera R
Oncogene; 1994 Jul; 9(7):1931-7. PubMed ID: 8208540
[TBL] [Abstract][Full Text] [Related]
7. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes.
Kim KE; Gu C; Thakur S; Vieira E; Lin JC; Rabson AB
Oncogene; 2000 Mar; 19(10):1334-45. PubMed ID: 10713675
[TBL] [Abstract][Full Text] [Related]
9. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
[TBL] [Abstract][Full Text] [Related]
10. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
11. Aberrant rel/nfkb genes and activity in human cancer.
Rayet B; Gélinas C
Oncogene; 1999 Nov; 18(49):6938-47. PubMed ID: 10602468
[TBL] [Abstract][Full Text] [Related]
12. Nfkb 1 is dispensable for Myc-induced lymphomagenesis.
Keller U; Nilsson JA; Maclean KH; Old JB; Cleveland JL
Oncogene; 2005 Sep; 24(41):6231-40. PubMed ID: 15940251
[TBL] [Abstract][Full Text] [Related]
13. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
14. Distinct activities of p52/NF-kappa B required for proper secondary lymphoid organ microarchitecture: functions enhanced by Bcl-3.
Poljak L; Carlson L; Cunningham K; Kosco-Vilbois MH; Siebenlist U
J Immunol; 1999 Dec; 163(12):6581-8. PubMed ID: 10586052
[TBL] [Abstract][Full Text] [Related]
15. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the Na(+)/K(+)/Cl(-) cotransporter gene induces cell proliferation and phenotypic transformation in mouse fibroblasts.
Panet R; Marcus M; Atlan H
J Cell Physiol; 2000 Jan; 182(1):109-18. PubMed ID: 10567922
[TBL] [Abstract][Full Text] [Related]
17. relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells.
Ricca A; Biroccio A; Trisciuoglio D; Cippitelli M; Zupi G; Del Bufalo D
Br J Cancer; 2001 Dec; 85(12):1914-21. PubMed ID: 11747334
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.
Loercher A; Lee TL; Ricker JL; Howard A; Geoghegen J; Chen Z; Sunwoo JB; Sitcheran R; Chuang EY; Mitchell JB; Baldwin AS; Van Waes C
Cancer Res; 2004 Sep; 64(18):6511-23. PubMed ID: 15374962
[TBL] [Abstract][Full Text] [Related]
19. Rearrangement and altered expression of the NFKB-2 gene in human cutaneous T-lymphoma cells.
Thakur S; Lin HC; Tseng WT; Kumar S; Bravo R; Foss F; Gélinas C; Rabson AB
Oncogene; 1994 Aug; 9(8):2335-44. PubMed ID: 8036016
[TBL] [Abstract][Full Text] [Related]
20. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]